Companies: 10,795·Total market cap: $144.5T
Globus Medical, Inc.

Globus Medical, Inc.

GMEDNYSEHealthcare● Active
$80.00
+$0.00(+0.00%)
Market Cap$10.8B
P/E Ratio—
52W High$101.4
52W Low$51.79
Cash on HandFinancialsRevenue

Globus Medical, Inc. (GMED) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GMED · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$557.2M▼ -37.4% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$526.2M
cashAndCashEquivalents
Short-Term Investments
$31.1M
shortTermInvestments
YoY Change vs Prior Year
-37.4%
vs prior fiscal year
Latest Quarter
$629.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$557.2MCash on Hand
Total Debt$118.7MTotal Debt
Net Cash / Net Debt+$438.6MNet Cash Position
Cash vs Debt Ratio
Cash 82%Debt 18%

Globus Medical, Inc. has a net cash position of $438.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$557.2M − $118.7M = +$438.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
GMED annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$557.2M-37.4%
Dec 31, 2024$890.1M+71.9%
Dec 31, 2023$517.8M+16.1%
Dec 31, 2022$446.1M+0.6%
Dec 31, 2021$443.4M+3.9%
GMED cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Globus Medical, Inc.
Globus Medical, Inc.YOU
GMED
$557.2M5.2%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Globus Medical, Inc. (GMED) cash on hand as of December 31, 2025 is $557.2M, comprising $526.2M in cash and cash equivalents (CCE) plus $31.1M in short-term investments — reported as Globus Medical, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Globus Medical, Inc. cash reserves or cash position.

Globus Medical, Inc. annual cash on hand history shows decreased -37.4% in 2025: decreased -37.4% in 2025. Globus Medical, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Globus Medical, Inc. carries total debt of $118.7M against cash of $557.2M, resulting in a net cash position of +$438.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

GMED cash on hand · 5 questions

As of December 31, 2025, Globus Medical, Inc. (GMED) has $557,243,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $526,156,000 in cash and cash equivalents (CCE) plus $31,087,000 in short-term investments. Latest quarter (March 31, 2026): $629,851,000. Data sourced from the annual 10-K filing via FMP.

GMED cash on handGMED cash reservesGMED cash 2025how much cash does GMED have

▸ Source: FMP /balance-sheet-statement · US GAAP · Globus Medical, Inc. · Globus Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025